BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

JDOCvsPBPHETF Comparison

ETF 1

JDOC

JPMorgan Healthcare Leaders ETF

This fund is part of

Global Blended Cap

+0.47%

Full JDOC fund page

VS

ETF 2

PBPH

Portfolio Building Block World Pharma and Biotech Index ETF

This fund is part of

DM Large & Mid Cap

+0.21%

Full PBPH fund page

JPMorgan Healthcare Leaders ETF (JDOC) belongs to the Global Blended Cap segment. Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) is part of the DM Large & Mid Cap segment. JDOC's top 2 sector exposures are Healthcare and Consumer Non-Cyclicals. In contrast, PBPH's top sector exposures are Healthcare. JDOC is more expensive with a Total Expense Ratio (TER) of 0.65%, versus 0.13% for PBPH. JDOC is up 10.6% year-to-date (YTD) with -$34K in YTD flows. PBPH performs better with 18.76% YTD performance, and +$1.00B in YTD flows. Run a side-by-side ETF comparison of JDOC and PBPH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

JDOC vs PBPH performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 10/28/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	JDOC PBPH	+4.30%+4.21%	+2.92%+7.13%	+10.60%+18.76%	+16.91%n/a	+33.69%n/a	n/an/a
Flows	JDOC PBPH	-+$15M	-+$67M	-$34K+$1.00B	-$34K-	+$7M-	--

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	JDOC PBPH	+15.74%+19.29%	+15.54%n/a	+14.83%n/a	n/an/a
Max drawdown	JDOC PBPH	-7.92%-6.98%	-9.66%n/a	-24.04%n/a	n/an/a
Max drawdown duration	JDOC PBPH	64d55d	154dn/a	704dn/a	n/an/a

Trading data

Create an account to view trading data

Join for free

	JDOC	PBPH
Last sale 10/29/2026 at 1:30 PM	$65.34	$30.76
Previous close 10/28/2026	$64.05	$30.01
Consolidated volume 10/28/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of September 30, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

JDOC

is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free

	JDOC	PBPH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 10/29/2026 at 1:30 PM

Live

Closed

	JDOC	PBPH
Last price	$65.34	$30.76
1D performance	+2.03%	+2.51%
AuM	$9.60 M	$1.12 B
E/R	0.65%	0.13%

Characteristics

	JDOC	PBPH
Management strategy	Active	Passive
Provider	J.P. Morgan Asset Management	Tidal
Benchmark	-	BITA Global Pharma and Biotech Select Index
N° of holdings	57	52
Asset class	-	-
Trailing 12m distribution yield	Join	Join
Inception date	November 1, 2023	November 24, 2025
ESG	No	No

More JDOC data on Trackinsight

More PBPH data on Trackinsight

Exposure

Countries

JDOC

USA

73.86%

Other

26.14%

PBPH

USA

66.52%

Switzerland

10.05%

Other

23.44%

Sectors

JDOC

Healthcare

96.33%

Other

3.67%

PBPH

Healthcare

99.55%

Other

0.45%

Diversification

JDOC

Total weight of top 15 holdings out of 15

59.39%

PBPH

Total weight of top 15 holdings out of 15

74.6%

Top 15 holdings

Data as of August 31, 2026

JDOC

AbbVie, Inc.

7.91%

Eli Lilly & Co.

7.63%

Merck & Co., Inc.

5.32%

Johnson & Johnson

4.80%

Thermo Fisher Scientific, Inc.

4.15%

UnitedHealth Group, Inc.

3.64%

Bristol Myers Squibb Co.

3.52%

AstraZeneca PLC

3.48%

Abbott Laboratories

3.15%

Novo Nordisk A/S

2.95%

Roche Holding AG

2.80%

argenx SE

2.79%

Danaher Corp.

2.56%

GSK Plc

2.47%

CVS Health Corp.

2.24%

PBPH

Eli Lilly & Co.

14.74%

Johnson & Johnson

9.60%

AbbVie, Inc.

6.72%

Merck & Co., Inc.

5.42%

Amgen, Inc.

4.92%

Roche Holding AG

4.59%

Novartis AG

4.14%

Gilead Sciences, Inc.

3.99%

AstraZeneca PLC

3.52%

Pfizer Inc.

3.51%

Novo Nordisk A/S

3.23%

Vertex Pharmaceuticals, Inc.

3.02%

Bristol Myers Squibb Co.

2.99%

Sanofi

2.15%

GSK Plc

2.07%

Frequently asked questions about JDOC and PBPH

How have the JDOC and PBPH ETFs performed in 2026?

As of October 28, 2026, JDOC is up 10.6% year-to-date (YTD), while PBPH has returned 18.76%. That puts PBPH better performer ahead so far this year.

Which ETF is attracting more investor money: JDOC or PBPH?

Year-to-date, the JDOC ETF saw -$34K in flows, compared to +$1.00B for PBPH.

Which ETF is bigger: JDOC or PBPH?

As of October 28, 2026, JDOC holds $9.60 M in assets under management (AUM), while PBPH manages $1.12 B.

What sectors do the JDOC and PBPH ETFs invest in?

JDOC leans toward sectors like Healthcare. Meanwhile, PBPH focuses on Healthcare.

What are the top holdings of the JDOC ETF and PBPH ETF?

JDOC top holdings include AbbVie, Inc., Eli Lilly & Co. and Merck & Co., Inc.. PBPH holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

JDOCvsPBPHETF Comparison

JPMorgan Healthcare Leaders ETF

Portfolio Building Block World Pharma and Biotech Index ETF

JDOC vs PBPH performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the JDOC and PBPH ETFs performed in 2026?

As of October 28, 2026, JDOC is up 10.6% year-to-date (YTD), while PBPH has returned 18.76%. That puts PBPH better performer ahead so far this year.

Which ETF is attracting more investor money: JDOC or PBPH?

Year-to-date, the JDOC ETF saw -$34K in flows, compared to +$1.00B for PBPH.

Which ETF is bigger: JDOC or PBPH?

As of October 28, 2026, JDOC holds $9.60 M in assets under management (AUM), while PBPH manages $1.12 B.

What sectors do the JDOC and PBPH ETFs invest in?

JDOC leans toward sectors like Healthcare. Meanwhile, PBPH focuses on Healthcare.

What are the top holdings of the JDOC ETF and PBPH ETF?

JDOC top holdings include AbbVie, Inc., Eli Lilly & Co. and Merck & Co., Inc.. PBPH holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: JDOC or PBPH?

JDOC holds 58 securities with 59.39% of its assets in the top 15. PBPH has 53 securities and a top 15 weight of 74.6%.

ETFs’ Next Act: From Access to Selection